The role of nutraceuticals in male fertility

Urologic Clinics of North America

Volumn 41, Issue 1, 2014, Pages 181-193

  Ko, Edmund Y ^a   Sabanegh, Edmund S ^b  

^a LOMA LINDA UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Antioxidant; Diet; Male infertility; Nutraceutical; Supplement

Indexed keywords

ANTIOXIDANT; DIET; MALE INFERTILITY; NUTRACEUTICAL; SUPPLEMENT;

ANTIOXIDANTS; DIETARY SUPPLEMENTS; FERTILITY; HUMANS; INFERTILITY, MALE; MALE; OXIDATIVE STRESS;

EID: 84888299059     PISSN: 00940143     EISSN: 1558318X     Source Type: Journal    
DOI: 10.1016/j.ucl.2013.08.003     Document Type: Review

References (147)

1. Dharti T.S., Gandhi S., Shah M. Nutraceuticals-Portmanteau of science and nature. Int J Pharm Sci Rev Res 2010, 5(3):33-38.
2. Crimmel A.S., Conner C.S., Monga M. Withered yang: a review of traditional Chinese medical treatment of male infertility and erectile dysfunction. JAndrol 2001, 22:173-182.
3. Sharlip I.D., Jarow J.P., Belker A.M., et al. Best practice policies for male infertility. Fertil Steril 2002, 77:873-882.
4. Jarrow J, Sigman M, Kolettis PN, etal. The optimal evaluation of the infertile male: AUA best practice statement. Revised, 2010. Available at:. Accessed September 8, 2013. http://www.auanet.org/education/guidelines/male-infertility-d.cfm.
5. Agarwal A., Ikemoto I., Loughlin K.R. Relationship of sperm parameters with levels of reactive oxygen species in semen specimens. JUrol 1994, 152:107-110.
6. Kefer J.C., Agarwal A., Sabanegh E. Role of antioxidants in the treatment of male infertility. Int J Urol 2009, 16:449-457.
7. Henkel R., Kierspel E., Stalf T., et al. Effect of reactiveoxygen species produced by spermatozoa and leukocytes on sperm functions in non-leukocytospermicpatients. Fertil Steril 2005, 83:635-642.
8. Ebisch I.M., Thomas C.M., Peters W.H., et al. The importance of folate, zinc and antioxidants in the pathogenesis and prevention of subfertility. Hum Reprod Update 2007, 13:163-174.
9. Agarwal A., Saleh R.A., Bedaiwy M.A. Role of reactive oxygen species in the pathophysiology of human reproduction. Fertil Steril 2003, 79:829-843.
10. Ryan T.C., Weil G.J., Newburger P.E., et al. Measurement of superoxide release in the phagovacuoles of immune complex-stimulated human neutrophils. JImmunol Methods 1990, 130:223-233.
11. Kao S.H., Chao H.T., Chen H.W., et al. Increase in oxidative stress in human sperm with lower motility. Fertil Steril 2008, 89:1183-1190.
12. de Lamirande E., Lamothe G. Reactive oxygen-induced reactive oxygen formation during human sperm capacitation. Free Radic Biol Med 2009, 46:502-510.
13. Ross C., Morriss A., Khairy M., et al. Asystematic review of the effect of oral antioxidants on male infertility. Reprod Biomed Online 2010, 20:711-723.
14. Tremellen K. Oxidative stress and male infertility-a clinical perspective. Hum Reprod Update 2008, 14:243-258.
15. Keskes-Ammar L., Feki-Chakroun N., Rebai T., et al. Sperm oxidative stress and the effect of an oral vitamin E and selenium supplement on semen quality in infertile men. Arch Androl 2003, 49:83-94.
16. Agarwal A., Prabhakaran S.A., Sikka S.C. Clinical evidence of oxidative stress in patients with male factor infertility: evidence-based analysis. AUA Update Ser 2007, 26:1-12.
17. Young S.S., Eskenazi B., Marchetti F.M., et al. The association of folate, zinc, and antioxidant intake with sperm aneuploidy in healthy non-smoking men. Hum Reprod 2008, 23:1014-1022.
18. Mendiola J., Torres-Cantero A.M., Vioque J., et al. Alow intake of antioxidant nutrients is associated with poor semen quality in patients attending fertility clinics. Fertil Steril 2010, 93:1128-1133.
19. Brower V. Nutraceuticals: poised for a healthy slice of the healthcare market?. Nat Biotechnol 1998, 16:728-731.
20. Bagchi D. Nutraceuticals and functional foods regulations in the United States and around the world. Toxicology 2006, 221:1-3.
21. Kalra E.K. Nutraceutical - definition and introduction. AAPS PharmSci 2003, 5(3):1-2.
22. Appleton J. Arginine: clinical potential of a semi-essential amino. Altern Med Rev 2002, 7:512-522.
23. Sinclair S. Male infertility: nutritional and environmental considerations. Altern Med Rev 2000, 5:28-38.
24. Srivastava S., Agarwal A. Effect of anion channel blockers on L-arginine action in spermatozoa from asthenospermic men. Andrologia 2010, 42(2):76-82.
25. Holt L.E., Albanese A.A. Observations on amino acid deficiencies in man. Trans Assoc Am Physicians 1944, 58:143-156.
26. Tanimura J. Studies on arginine in human semen. Part II. The effects of medication with L-arginine-HCl on male infertility. Bull Osaka Med Sch 1967, 13:84-89.
27. Schachter A., Goldman J.A., Zukerman Z. Treatment of oligospermia with the amino acid arginine. JUrol 1973, 110:311-313.
28. De Aloysio D., Mantuano R., Mauloni M., et al. The clinical use of arginine aspartate in male infertility. Acta Eur Fertil 1982, 13:133-167.
29. Schibona M., Mseschini P., Capparelli S., et al. L-Arginine and male infertility. Minerva Urol Nefrol 1994, 46(4):251-253.
30. Miroueh A. Effect of arginine on oligospermia. Fertil Steril 1970, 21:217-219.
31. Pryor J.P., Blandy J.P., Evans P., et al. Controlled clinical trial of arginine for infertile men with oligozoospermia. Br J Urol 1978, 50:47-50.
32. Morris S.M., Loscalzo J., Bier D., et al. Arginine metabolism enzymology, nutrition, and clinical significance. JNutr 2004, 134(Suppl 10S):2741S-2897S.
33. Palmero S., Bottazzi C., Costa M., et al. Metabolic effects of L-carnitine on prepubertal rat Sertoli cells. Horm Metab Res 2000, 32:87-90.
34. Vicari E., LaVignera S., Calogero A. Antioxidant treatment with carnitines is effective in infertile patients with prostatovesiculoepididymitis and elevated seminal leukocyte concentrations after treatment with nonsteroidal anti-inflammatory compounds. Fertil Steril 2002, 6:1203-1208.
35. Bohmer T., Hoel P., Purvis K., et al. Carnitine levels in human accessory sex organs. Arch Androl 1978, 1:53-59.
36. Moncada M.L., Vicari E., Cimino C., et al. Effect of acetylcarnitine treatment in oligoasthenospermic patients. Acta Eur Fertil 1992, 23:221-224.
37. Costa M., Canale D., Filicori M., et al. L-Carnitine in idiopathic asthenozoospermia: a multicenter study. Italian Study Group on Carnitine and Male Infertility. Andrologia 1994, 26:155-159.
38. Vitali G., Parente R., Melotti C. Carnitine supplementation in human idiopathic asthenospermia: clinical results. Drugs Exp Clin Res 1995, 21:157-159.
39. Vicari E., Calogero A.E. Effects of treatment with carnitines in infertile patients with prostato-vesiculo-epididymitis. Hum Reprod 2001, 16:2338-2342.
40. Lenzi A., Sgro P., Salacone P., et al. Aplacebo-controlled double-blind randomized trial in the use of combined L-carnitine and L-acetyl-carnitine treatment in men with asthenozoospermia. Fertil Steril 2004, 81:1578-1584.
41. Balercia G., Regoli F., Armeni T., et al. Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermia. Fertil Steril 2005, 84:662-671.
42. de Rosa M., Boggia B., Amalfi B., et al. Correlation between seminal carnitine and functional spermatozoal characteristics in men with semen dysfunction of various origins. Drugs R D 2005, 6:1-9.
43. Zhou X., Liu F., Zhai S. Effect of L-carnitine and/or L-acetyl-carnitine in nutrition treatment for male infertility: a systematic review. Asia Pac J Clin Nutr 2007, 16:383-390.
44. Cavallini G., Ferraretti A.P., Gianarolli L., et al. Cinnoxicam and L-carnitine/acetyl-L-carnitine treatment for idiopathic and varicocoele-associated oligoasthenospermia. JAndrol 2004, 25:761-770.
45. Sigman M., Glass S., Campagnone J., et al. Carnitine for the treatment of idiopathic asthenospermia: a randomized, double-blind, placebo-controlled trial. Fertil Steril 2006, 85:1409-1414.
46. Evans A.M., Fornasini G. Pharmacokinetics of L-carnitine. Clin Pharmacokinet 2003, 42:941-967.
47. Rebouche C.J. Carnitine function and requirements during the life cycle. FASEB J 1992, 6:3379-3386.
48. Manual of nutritional therapeutics 2008, Lippincott Williams & Wilkins, Philadelphia. 5th edition. D.H. Alpers, W.F. Stenson, B.E. Taylor (Eds.).
49. Hidaka T., Fujii K., Funahashi I., et al. Safety assessment of coenzyme Q10 (CoQ10). Biofactors 2008, 32:199-208.
50. Littarru G.P., Tiano L. Clinical aspects of coenzyme Q10: an update. Nutrition 2010, 26:250-254.
51. Balercia G., Buldreghini E., Vignini A., et al. Coenzyme Q10 treatment in infertile men with idiopathic asthenozoospermia: a placebo-controlled, double-blind randomized trial. Fertil Steril 2009, 91:1785-1792.
52. Bentinger M., Tekle M., Dallner G. Coenzyme Q-biosynthesis and functions. Biochem Biophys Res Commun 2010, 396:74-79.
53. Mancini A., De Marinis L., Oradei A., et al. Coenzyme Q10 concentrations in normal and pathological human seminal fluid. JAndrol 1994, 15:591-594.
54. Safarinejad M.R. Efficacy of coenzyme Q10 onsemen parameters, sperm function and reproductive hormones in infertile men. JUrol 2009, 182:237-248.
55. Pravst I., Zmitek K., Zmitek J. Coenzyme Q10 contents in foods and fortification strategies. Crit Rev Food Sci Nutr 2010, 50:269-280.
56. Joshi R., Adhikari S., Patro B.S., et al. Free radical scavenging behavior of folic acid: evidence for possible antioxidant activity. Free Radic Biol Med 2001, 30:1390-1399.
57. Wong W.Y., Merkus H.M., Thomas C.M., et al. Effects of folic acid and zinc sulfate on male factor subfertility: a double-blind, randomized, placebo-controlled trial. Fertil Steril 2002, 77:491-498.
58. Landau B., Singer R., Klein T., et al. Folic acid levels in blood and seminal plasma of normo- and oligospermic patients prior and following folic acid treatment. Experientia 1978, 34:1301-1302.
59. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine Dietary reference intakes for thiamine, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline 2000, National Academies Press, Washington, DC.
60. Rogovik A.L., Vohra S., Goldman R.D. Safety considerations and potential interactions of vitamins: should vitamins be considered drugs?. Ann Pharmacother 2010, 44:311-324.
61. Lange H., Suryapranata H., De Luca G., et al. Folate therapy and in-stent restenosis after coronary stenting. NEngl J Med 2004, 350:2673-2681.
62. Bonaa K.H., Njolstad I., Ueland P.M., NORVIT Trial Investigators, et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. NEngl J Med 2006, 354:1578-1588.
63. Irvine D.S. Glutathione as a treatment for male infertility. Rev Reprod 1996, 1:6-12.
64. Pompella A., Visvikis A., Paolicchi A., et al. The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol 2003, 66:1499-1503.
65. Lenzi A., Lombardo F., Gandini L., et al. Glutathione therapy for male infertility. Arch Androl 1992, 29:65-68.
66. Lenzi A., Picardo M., Gandini L., et al. Glutathione treatment of dyspermia: effect on the lipoperoxidation process. Hum Reprod 1994, 9:2044-2050.
67. Lenzi A., Culasso F., Gandini L., et al. Placebo-controlled, double blind, cross-over trial of glutathione therapy in male infertility. Hum Reprod 1993, 8:1657-1662.
68. Kodama H., Yamaguchi R., Fukuda J., et al. Increased oxidative deoxyribonucleic acid damage in the spermatozoa of infertile male patients. Fertil Steril 1997, 68:519-524.
69. Jones D.P., Coates R.J., Flagg E.W., et al. Glutathione in foods listed in the National Cancer Institute's Health Habits and History Food Frequency Questionnaire. Nutr Cancer 1992, 17:57-75.
70. Witschi A., Reddy S., Stofer B., et al. The systemic availability of oral glutathione. Eur J Clin Pharmacol 1992, 43:667-669.
71. Borgstrom L., Kagedal B., Paulsen O. Pharmacokinetics of N-acetylcysteine in man. Eur J Clin Pharmacol 1986, 31:217-222.
72. Micke P., Beeh K.M., Schlaak J.F., et al. Oral supplementation with whey proteins increases plasma glutathione levels of HIV-infected patients. Eur J Clin Invest 2001, 31:171-178.
73. Shay K.P., Moreau R.F., Smith E.J., et al. Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim Biophys Acta 2009, 1790:1149-1160.
74. Rao A.V., Mira M.R., Rao L.G. Lycopene. Adv Food Nutr Res 2006, 51:99-164.
75. Rao A.V., Rao L.G. Carotenoids and human health. Pharmacol Res 2007, 55:207-216.
76. Goyal A., Chopra M., Lwaleed B.A., et al. The effects of dietary lycopene supplementation on human seminal plasma. BJU Int 2007, 99:1456-1460.
77. Gupta N.P., Kumar R. Lycopene therapy in idiopathic male infertility-a preliminary report. Int Urol Nephrol 2002, 34:369-372.
78. Safarinejad M.R., Safarinejad S. The roles of omega-3 and omega-6 fatty acids in idiopathic male infertility. Asian J Androl 2012, 14:514-515.
79. Farooqui A.A., Horrocks L.A., Farooqui T. Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders. Chem Phys Lipids 2000, 106:1-29.
80. Mazza M., Pomponi M., Janiri L., et al. Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:12-26.
81. Lenzi A., Gandini L., Maresca V., et al. Fatty acid composition of spermatozoa and immature germ cells. Mol Hum Reprod 2000, 6:226-231.
82. Safarinejad M.R., Hosseini S.Y., Dadkhah F., et al. Relationship of omega-3 and omega-6 fatty acids with semen characteristics, and anti-oxidant status of seminal plasma: a comparison between fertile and infertile men. Clin Nutr 2010, 29:100-105.
83. Safarinejad M.R. Effect of omega-3 polyunsaturated fatty acid supplementation on semen profile and enzymatic anti-oxidant capacity of seminal plasma in infertile men with idiopathic oligoasthenoteratospermia: a double-blind, placebo-controlled, randomised study. Andrologia 2011, 43:38-47.
84. Attaman J.A., Toth T.L., Furtado J., et al. Dietary fat and semen quality among men attending a fertility clinic. Hum Reprod 2012, 27:1466-1474.
85. Gebauer S.K., Psota T.L., Harris W.S., et al. n-3 Fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr 2006, 83(Suppl):1526S-1535S.
86. Institute of Medicine Dietary reference intakes: energy, carbohydrates, fiber, fat, fatty acids, cholesterol, protein, and amino acids 2002, National Academies Press, Washington, DC.
87. Food and Nutrition Board Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids 2005, vol. 423:770. Institute of Medicine of the National Academies, Washington, DC.
88. Buckley M.S., Goff A.D., Knapp W.E., et al. Fish oil interaction with warfarin. Ann Pharmacother 2004, 38:50-52.
89. Chan E.J., Cho L. What can we expect from omega-3 fatty acids?. Cleve Clin J Med 2009, 76(4):245-251. [review].
90. Kuiper G.G., Carlsson B., Grandien K., et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997, 138:863-870.
91. Kuiper G.G., Lemmen J.G., Carlsson B., et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139:4252-4263.
92. Cederroth C.R., Zimmermann C., Nef S. Soy, phytoestrogens and their impact on reproductive health. Mol Cell Endocrinol 2012, 355:192-200.
93. Cederroth C.R., Auger J., Zimmermann C., et al. Soy, phyto-oestrogens and male reproductive function: a review. Int J Androl 2009, 33:304-316.
94. Cederroth C.R., Nef S. Soy, phytoestrogens and metabolism: a review. Mol Cell Endocrinol 2009, 304:30-42.
95. Vedavanam K., Srijayanta S., O'Reilly J., et al. Antioxidant action and potential antidiabetic properties of an isoflavonoid-containing soyabean phytochemical extract. Phytother Res 1999, 13:601-608.
96. Bhathena S.J., Valasquez M.T. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 2000, 76:1191-1201.
97. US Department of Agriculture, ARS. USDA database for the isoflavone content of selected foods. 2008, Release 2.0. Available at:. Accessed September 8, 2013. http://www.ars.usda.gov/SP2UserFiles/Place/12354500/Data/isoflav/Isoflav_R2.pdf.
98. Ho S.C., Woo J.L., Leung S.S., et al. Intake of soy products is associated with better plasma lipid profiles in the Hong Kong Chinese population. JNutr 2000, 130:2590-2593.
99. Nagata C., Inaba S., Kawakami N., et al. Inverse association of soy product intake with serum androgen and estrogen concentrations in Japanese men. Nutr Cancer 2000, 36:14-18.
100. Song G., Kochman L., Andolina E., et al. Beneficial effects of dietary intake of plant phytoestrogens on semen parameters and sperm DNA integrity in infertile men. Fertil Steril 2006, 86:S49.
101. Chavarro J.E., Toth T.L., Sadio S.M., et al. Soy food and isoflavone intake in relation to semen quality parameters among men from an infertility clinic. Hum Reprod 2008, 23:2584-2590.
102. Mitchell J.H., Cawood E., Kinniburgh D., et al. Effect of a phytoestrogen food supplement on reproductive health in normal males. Clin Sci 2001, 100:613-618.
103. Hamilton-Reeves J.M., Vasquez G., Duval S.J., et al. Clinical studies show no effects of soy protein or isoflavones on reproductive hormones in men: results of a meta-analysis. Fertil Steril 2010, 94:997-1007.
104. Patisaul H.B., Jefferson W. The pros and cons of phytoestrogens. Front Neuroendocrinol 2010, 31(4):400-419.
105. Brown K.M., Arthur J.R. Selenium, selenoproteins and human health: a review. Public Health Nutr 2001, 4:593-599.
106. Wallace E., Calvin H.I., Ploetz K., et al. Functional and developmental studies on the role of selenium in spermatogenesis. Selenium in biology and medicine. Pt A 1987, 181-196. Van Nostrand Reinhold, New York. G.F. Coombs, J.E. Spallholz, O.A. Levander (Eds.).
107. Ursini F., Heim S., Kiess M., et al. Dual function of the selenoprotein PHGPx during sperm maturation. Science 1999, 285:1393-1396.
108. Watanabe T., Endo A. Effects of selenium deficiency on sperm morphology and spermatocyte chromosomes in mice. Mutat Res 1991, 262:93-99.
109. Noack-Fuller G., De Beer C., Seibert H. Cadmium, lead, selenium, and zinc in semen of occupationally unexposed men. Andrologia 1993, 25:7-12.
110. Vezina D., Mauffette F., Roberts K.D., et al. Selenium-vitamin E supplementation in infertile men. Effects on semen parameters and micronutrient levels and distribution. Biol Trace Elem Res 1996, 53:65-83.
111. Safarinejad M.R., Safarinejad S. Efficacy of selenium and/or N-acetyl-cysteine for improving semen parameters in infertile men: a double-blind, placebo controlled, randomized study. JUrol 2009, 181:741-751.
112. Burton G.W., Traber M.G. Vitamin E: antioxidant activity, biokinetics, and bioavailability. Annu Rev Nutr 1990, 10:357-382.
113. Scott R., MacPherson A., Yates R.W., et al. The effect of oral selenium supplementation on human sperm motility. Br J Urol 1998, 82:76-80.
114. Iwanier K., Zachara B.A. Selenium supplementation enhances the element concentration in blood and seminal fluid but does not change the spermatozoal quality characteristics in subfertile men. JAndrol 1995, 16:441-447.
115. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine Dietary reference intakes for vitamin C, vitamin E, selenium, and beta-carotene and other carotenoids 2000, National Academies Press, Washington, DC.
116. Yang G.Q., Wang S.Z., Zhou R.H., et al. Endemic selenium intoxication of humans in China. Am J Clin Nutr 1983, 37:872-881.
117. Kamal-Eldin A., Appelqvist L.A. The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids 1996, 31:671-701.
118. Chung S.S., Wolgemuth D.J. Role of retinoid signaling in the regulation of spermatogenesis. Cytogenet Genome Res 2004, 105:189-202.
119. Morales A., Cavicchia J.C. Spermatogenesis and blood-testis barrier in rats after long-term vitamin A deprivation. Tissue Cell 2002, 34:349-355.
120. Galatioto G.P., Gravina G.L., Angelozzi G., et al. May antioxidant therapy improve sperm parameters of men with persistent oligospermia after retrograde embolization for varicocele?. World J Urol 2008, 26:97-102.
121. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc 2001, National Academies Press, Washington, DC.
122. Ovesen L. Vitamin therapy in the absence of obvious deficiency. What is the evidence?. Drugs 1984, 27:148-170.
123. Linster C.L., Van Schaftingen E., Vitamin C. Biosynthesis, recycling and degradation in mammals. FEBS J 2007, 274:1-22.
124. Greco E., Iacobelli M., Rienzi L., et al. Reduction of the incidence of sperm DNA fragmentation by oral antioxidant treatment. JAndrol 2005, 26:349-353.
125. Dawson E.B., Harris W.A., Rankin W.E., et al. Effect of ascorbic acid on male fertility. Ann N Y Acad Sci 1987, 498:312-323.
126. Colagar A.H., Marzony E.T. Ascorbic acid in human seminal plasma: determination and its relationship to sperm quality. JClin Biochem Nutr 2009, 45:144-149.
127. Baker H.W., Brindle J., Irvine D.S., et al. Protective effect of antioxidants on the impairment of sperm motility by activated polymorphonuclear leukocytes. Fertil Steril 1996, 65:411-419.
128. Eskenazi B., Kidd S.A., Marks A.R., et al. Antioxidant intake is associated with semen quality in healthy men. Hum Reprod 2005, 20:1006-1012.
129. Omu A.E., Al-Azemi M.K., Kehinde E.O., et al. Indications of the mechanisms involved in improved sperm parameters by zinc therapy. Med Princ Pract 2008, 17:108-116.
130. Rolf C., Cooper T.G., Yeung C.H., et al. Antioxidant treatment of patients with asthenozoospermia or moderate oligoastheno-zoospermia with high-dose vitamin C and vitamin E: a randomized, placebo-controlled, double-blind study. Hum Reprod 1999, 14:1028-1033.
131. Dawson E.B., Harris W.A., Teter M.C., et al. Effect of ascorbic acid supplementation on the sperm quality of smokers. Fertil Steril 1992, 58:1034-1039.
132. Abel B.J., Carswell G., Elton R. Randomised trial of clomiphene citrate treatment and vitamin C for male infertility. BJU Int 1983, 54:780-784.
133. Palamanda J.R., Kehrer J.R. Involvement of vitamin E and protein thiols in the inhibition of microsomal lipid peroxidation by glutathione. Lipids 1993, 23:427-443.
134. Brigelius-Flohe R., Traber M.G. Vitamin E: function and metabolism. FASEB J 1999, 13:1145-1155.
135. Kessopoulou E., Powers H.J., Sharma K.K., et al. Adouble-blind randomized placebo cross-over controlled trial using the antioxidant vitamin E to treat reactive oxygen species associated male infertility. Fertil Steril 1995, 64:825-831.
136. Suleiman S.A., Ali M.E., Zaki Z.M., et al. Lipid peroxidation and human sperm motility: protective role of vitamin E. JAndrol 1996, 17:530-537.
137. Bendich A. Safety issues regarding the use of vitamin supplements. Ann N Y Acad Sci 1992, 669:300-310.
138. Lonn E., Bosch J., Yusuf S., HOPE and HOPE-TOO Trial Investigators, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005, 293:1338-1347.
139. Miller E.R., Pastor-Barriuso R., Dalal D., et al. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005, 142:37-46.
140. Weber P., Bendich A., Machlin L.J. Vitamin E and human health: rationale for determining recommended intake levels. Nutrition 1997, 13:450-460.
141. Mousa S.A. Antithrombotic effects of naturally derived products on coagulation and platelet function. Methods Mol Biol 2010, 663:229-240.
142. Zago M.P., Oteiza P.I. The antioxidant properties of zinc: interactions with iron and antioxidants. Free Radic Biol Med 2001, 31:266-274.
143. Maret W., Sandstead H.H. Zinc requirements and the risks and benefits of zinc supplementation. JTrace Elem Med Biol 2006, 20:3-18.
144. Prasad A.S. Zinc in human health: effect of zinc on immune cells. Mol Med 2008, 14:353-357.
145. Hunt J.R. Bioavailability of iron, zinc, and other trace minerals from vegetarian diets. Am J Clin Nutr 2003, 78(Suppl 3):633S-639S.
146. Agarwal A., Sekhon L.H. The role of antioxidant therapy in the treatment of male infertility. Hum Fertil 2010, 13:217-225.
147. Showell M.G., Brown J., Yazdani A., et al. Antioxidants for male subfertility. Cochrane Database Syst Rev 2011, (1). CD007411.